You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 6, 2024

CLINICAL TRIALS PROFILE FOR SITAGLIPTIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for sitagliptin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00087516 ↗ Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021) Completed Merck Sharp & Dohme Corp. Phase 3 2004-06-01 The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00095056 ↗ An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2004-10-01 The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function).
NCT00103857 ↗ MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) Completed Merck Sharp & Dohme Corp. Phase 3 2005-03-17 The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus (T2DM) (a specific type of diabetes).
NCT00127192 ↗ A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) Completed Merck Sharp & Dohme Corp. Phase 2 2005-07-01 The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with type 2 diabetes mellitus.
NCT00305604 ↗ Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2006-03-08 To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for sitagliptin

Condition Name

Condition Name for sitagliptin
Intervention Trials
Type 2 Diabetes Mellitus 114
Diabetes Mellitus, Type 2 84
Type 2 Diabetes 70
Diabetes 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for sitagliptin
Intervention Trials
Diabetes Mellitus 298
Diabetes Mellitus, Type 2 293
Diabetes Mellitus, Type 1 18
Glucose Intolerance 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for sitagliptin

Trials by Country

Trials by Country for sitagliptin
Location Trials
Canada 107
India 89
China 88
Mexico 61
Germany 53
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for sitagliptin
Location Trials
Texas 72
California 72
Florida 67
Ohio 51
Georgia 48
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for sitagliptin

Clinical Trial Phase

Clinical Trial Phase for sitagliptin
Clinical Trial Phase Trials
Phase 4 137
Phase 3 125
Phase 2/Phase 3 10
[disabled in preview] 57
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for sitagliptin
Clinical Trial Phase Trials
Completed 333
Unknown status 33
Terminated 30
[disabled in preview] 29
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sitagliptin

Sponsor Name

Sponsor Name for sitagliptin
Sponsor Trials
Merck Sharp & Dohme Corp. 125
Novo Nordisk A/S 18
Eli Lilly and Company 15
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for sitagliptin
Sponsor Trials
Industry 310
Other 289
NIH 15
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.